💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Coloplast Q3 profits rise, ups margin view

Published 08/14/2009, 07:14 AM
Updated 08/14/2009, 07:18 AM

COPENHAGEN, Aug 14 (Reuters) - Danish healthcare products maker Coloplast posted a 2 percent rise in operating profits for the third quarter of its 2008-09 fiscal year, roughly in line with forecasts, and slightly raised its guidance for full-year margins.

Earnings before interest and tax (EBIT) rose to 347 million Danish crowns ($66.54 million) in the three months to end-June from 341 million in the same quarter last year, the company said on Friday.

The result missed an average expectation of a rise to 351 million in a Reuters survey of eight analysts, but came within the range of estimates of 313 million to 380 million crowns.

Coloplast bumped up its full-year 2008-09 guidance for its operating profit margin in Danish crown terms to 15-16 percent from an earlier projection of around 15 percent.

But it trimmed its full-year forecast for organic revenue growth in Danish crowns to around 5 percent from an earlier projection of around 6 percent.

Coloplast said it would not complete the rest of a share buy-back programme planned for 2009 because it wanted to strengthen its capital reserves and because the situation in the financial markets was not advantageous.

(Reporting by Copenhagen newsroom)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.